Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Cancer

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Never mind the quality--count the points: the effectiveness of the nGMS contract.

The British journal of general practice : the journal of the Royal College of General Practitioners·2006

Same author

Roles, power and subjective choice.

Patient education and counseling·2005

Same author

Learning with Donald Rumsfeld - flexible learning: the relevance and resonance of multiprofessional learning in primary care.

The British journal of general practice : the journal of the Royal College of General Practitioners·2004

Same author

What information patients with localised prostate cancer hear and understand.

Patient education and counseling·2003

Same author

Information on video format can help patients with localised prostate cancer to be partners in decision making.

Patient education and counseling·2003

Same author

Factors affecting the shift towards a 'primary care-led' NHS: a qualitative study. National Health Service.

The British journal of general practice : the journal of the Royal College of General Practitioners·2002

Search research articles

Related Experiment Video

Updated: Jun 2, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Surviving cancer without compromising aspirations.

Sandra McGregor¹

¹University of Glasgow, United Kingdom. Sandra.McGregor@glasgow.ac.uk

European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society

|April 26, 2011

Summary

This summary is machine-generated.

This paper details a 20-year journey of coping with metastatic cancer. A strategy of embracing the disease while refusing to compromise life goals led to valuable survival and personal growth.

Related Experiment Videos

Last Updated: Jun 2, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Area of Science:

Oncology
Psychology
Personal Narrative

Background:

A 20-year experience with numerous metastatic cancer incidences.
The complex process of surviving cancer and managing the threat of recurrence.

Purpose of the Study:

To reflect on coping, survival, and personal growth following prolonged metastatic cancer.
To explore strategies for redefining normality and finding meaning amidst chronic illness.

Main Methods:

Personal reflection and narrative account of a 20-year journey with metastatic cancer.
Description of coping strategies including embracing the disease and setting aside fear.
Analysis of how maintaining career focus influenced the perception of survival.

Main Results:

Development of a coping strategy that integrated the disease without compromising life aspirations.
Redefinition of normality and acceptance of living with cancer, fear of recurrence, and mortality.
Focusing on career and immediate stressors facilitated setting aside personal health worries, enhancing the value of survival.

Conclusions:

Maintaining life direction and career focus is crucial for valuable survival with metastatic cancer.
Acceptance and integration of cancer into life allows for continued growth and redefined normality.
Personal meaning can be found by actively engaging with life despite the challenges of chronic illness and potential mortality.